SLC5A2 and type 2 diabetes mellitus: Improved functionality of β-cells means that THCV aids in insulin secretion and supports pancreatic health in order to control the overall blood glucose levels of T2DM patients [31], whereas synthetic SGLT2 inhibitors induce glucose excretion.